Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,416,182
-$690,185 QoQ
Shares Held
30,449
-25.3% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#119
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Derivatives in SUPN

reported options exposure · as of Jun 30, 2026
CallValue
$939,502
CallShares
20,200
PutValue
$3,446,391
PutShares
74,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. SUPN ranks #18 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,504,358 $108,103,165
2 UTHR
UNITED THERAPEUTICS Corp
 88,579 $47,994,759
3 LQDA
Liquidia Corp
 471,067 $37,558,171
4 BCRX
Biocryst Pharmaceuticals Inc
 1,195,651 $11,956,510
5 PRGO
PERRIGO Co plc
 1,149,496 $11,943,263
6 HROW
Harrow, Inc.
 190,116 $8,074,226
7 VTRS
Viatris Inc
 295,261 $4,688,744
8 TLRY
Tilray Brands, Inc.
 1,021,777 $4,587,778

All Filings in SUPN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,416,182 30,449
2026-06-30 $939,502 20,200
2026-06-30 $3,446,391 74,100
2026-03-31 $2,106,367 40,750
2026-03-31 $925,251 17,900
2026-03-31 $2,822,274 54,600
2025-12-31 $357,840 7,200
2025-12-31 $1,207,710 24,300
2025-12-31 $2,086,604 41,984
2025-09-30 $530,469 11,100
2025-09-30 $1,498,742 31,361
2025-06-30 $2,164,636 68,675
2025-03-31 $2,628,285 80,253
2024-12-31 $368,832 10,200
2024-12-31 $1,131,446 31,290
2024-09-30 $271,266 8,700
2024-09-30 $625,907 20,074
2024-09-30 $395,986 12,700
2024-06-30 $211,325 7,900
2024-06-30 $462,775 17,300
2024-06-30 $331,753 12,402
2024-03-31 $1,903,338 55,800
2024-03-31 $217,110 6,365
2024-03-31 $842,517 24,700
2023-12-31 $231,520 8,000
2023-12-31 $469,638 16,228
2023-12-31 $486,192 16,800
2023-09-30 $1,013,941 36,777
2023-09-30 $443,877 16,100
2023-06-30 $270,540 9,000
2023-06-30 $1,402,989 46,673
2023-06-30 $432,864 14,400
2023-03-31 $1,649,769 45,536
2023-03-31 $670,255 18,500
2022-12-31 $613,524 17,200
2022-09-30 $335,115 9,900
2022-09-30 $1,025,655 30,300
2022-09-30 $566,750 16,743
2022-06-30 $257,388 8,900
2022-06-30 $1,061,364 36,700
2022-03-31 $1,276,640 39,500
2022-03-31 $743,360 23,000
2021-12-31 $1,116,828 38,300
2021-12-31 $822,895 28,220
2021-12-31 $720,252 24,700
2021-09-30 $698,754 26,200
2021-09-30 $440,055 16,500
2021-09-30 $500,542 18,768
2021-06-30 $646,590 21,000
2021-06-30 $375,638 12,200